Tranexamic acid was originally a prescription oral medication used to prevent excessive bleeding. Researchers noticed that patients taking it for medical reasons experienced unexpected improvements in melasma — which led to extensive investigation into its skin-brightening mechanism. It turns out tranexamic acid interferes with the communication between keratinocytes and melanocytes, disrupting the cascade that tells skin to produce excess pigment in response to UV exposure or inflammation.
What makes tranexamic acid stand out in the crowded hyperpigmentation-treatment category is its tolerability. Unlike hydroquinone (which can cause paradoxical darkening and rebound with long-term use), kojic acid (which irritates many skin types), or mercury-containing compounds (which are harmful), tranexamic acid is gentle, non-irritating, and compatible with sensitive skin. It's increasingly being studied alongside niacinamide and vitamin C as part of multitarget brightening protocols.